The proposed legislation aims to do three things: require drugmakers to reimburse Medicare if their prices surpass inflation rates, allow the HHS negotiation power when it comes to pricing drugs, and lowering the copay for Medicare and Medicaid recipients.
With a six-figure check, the National Association of Manufacturers launched ads targeting the bill, according to The Hill.
“Price controls are a hidden tax on manufacturers that harms innovation, competitiveness and R&D investments in new cures,” the ad’s narrator says. “Politicians shouldn’t force price controls on Americans that harm manufacturers’ ability to develop innovative, new cures to diseases.”
Some features of the bill are expected to pass, such as the Medicare and Medicaid copay limitation, but others face an unclear future since they were part of President Joe Biden’s once larger Build Back Better bill, which legislators have whittled down for months.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
